Matthew P. Blischak - Chief Executive Officer at Finch Therapeutics Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer
Stock Symbol
FNCH on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew P. Blischak since 12/22/2023

Holdings reported by Matthew P. Blischak for Finch Therapeutics Group, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 963K Jun 9, 2023 Direct Common Stock

Transactions reported by Matthew P. Blischak for Finch Therapeutics Group, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.